Dunlavin was alive with the sounds of music and song when the community came together at St Nicholas Church of Ireland for a ...

BETHESDA, MARYLAND / ACCESS Newswire / March 28, 2025 / Solaxa Inc., a biopharmaceutical public benefit corporation focused on rare neurological conditions, has announced plans to conduct a ...

Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...

When he was 19, he was halfway through a tattoo apprenticeship when he was diagnosed with Friedreich's Ataxia (FA)—a degenerative neuromuscular disorder that's debilitating and life-shortening.

A service dog bolted from a veterinary office in Amesbury, and it took the police with a high-tech drone to find her.

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

We are pleased to share further regulatory clarity for LX2006 for the treatment of Friedreich ataxia cardiomyopathy, and we appreciate the ...

Anthony Monaco was a very active teen—involved in soccer, wrestling, and even cross country—but he always felt a little awkward physically. It started with running a little differently than the kids ...

Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...

In Hyderabad, thanks to tall concrete buildings, narrow streets, cement surfaces, and dwindling green cover, there is always ...